Clinical Trial Update: Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Avastin with radiation and temozolomide, followed by Avastin/temozolomide/topotecan in glioblastoma patients; study completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma
• Malignant Glioma

Drugs mentioned

• Avastin (bevacizumab)
• Radiation (XRT) (radiation therapy)
• Temodar (Temozolomide)
• Topotecan (topotecan)

Snippet

Sponsor: Duke University | Conditions: Malignant Glioma, Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2013-01-18